1. How can I have naloxone on site for staff to use?
All staff and volunteers who may administer naloxone need to be trained in the use of naloxone and how to recognize an overdose. It is required to have an MD/DO or NP provide clinical oversight for your training program, although beginning 10/6/2017, training requirements will no longer be specifically outlined in statute or rule. It is also within the scope of practice for a PA to provide clinical oversight. The PA’s supervising physician must (1) delegate that responsibility in the PA’s practice agreement, (2) be competent to provide naloxone training, and (3) ensure the PA’s competence. The person providing clinical oversight can also order naloxone for your organization. . If you do not have an MD/DO, NP or PA on staff, talk to your local pharmacist about having them order naloxone for your organization.
If you do not have an MD/DO, NP, or PA on staff and are located in Multnomah, Clackamas, or Washington County, you may have a staff member attend the Naloxone Train-the-Trainer class sponsored by Multnomah County. Organizations who have a representative attend the training are able to purchase naloxone through the Multnomah County Pharmacy. Contact Erin Browne (firstname.lastname@example.org) for more information.
2. How can our staff be trained?
The MD/DO, NP or PA providing clinical oversight will determine the specific training protocols for your organization. Staff may be trained face-to-face, by watching the OHA online training videos, or by reading OHA training protocol (pdf). Face-to-face training can be provided by the person providing clinical oversight or by another staff member. There are no specific requirements for trainers.
3. Do staff and/or trainers need to be certified in CPR to administer naloxone or to train others to administer naloxone?
While CPR training may be beneficial to your staff and organization, it is not required for staff or trainers to be CPR certified.
4. What is involved in providing clinical oversight?
Clinical oversight for naloxone training protocols may be provided by an MD/DO, NP or PA (see #1 above for PA requirements). Oversight means ensuring, through periodic review, that the training on lifesaving treatments for opioid overdose is consistent with the scope and intent of the protocols developed by the Oregon Health Authority. The health professional providing clinical oversight can determine the appropriate level of oversight in the context of each organization’s staffing and outreach/training approach.
Law enforcement agencies needing more information can contact Lines for Life for assistance: ElizabethW@linesforlife.org. The Multnomah County Sheriff's Office created a naloxone training video for law enforcement.
5. Is starting a naloxone distribution program right for my organization?
If your agency works with clients at risk for opioid overdose, then starting a distribution program might be right for you. A naloxone distribution program includes training and distributing take-home naloxone kits to clients. Since staff will be training clients and distributing naloxone, clinical oversight by an MD/DO, NP, or PA is required, although this will no longer be required beginning January 1, 2018.
You may contact Lisa Shields at email@example.com for more information.
Here are some questions to consider when starting a program:
- Have you identified an MD/DO, NP or PA to provide clinical oversight for trainers?
- How will you document who has been trained by your trainers?
- What other data will you collect from participants? (ie: demographics, substance use history, overdose experiences, etc.)
- How often will staff be expected to do refresher trainings?
- How (and when) will you have your naloxone supplies available?
- Do you know how to order supplies for naloxone kits?
- Where will you store the naloxone kits?